195 related articles for article (PubMed ID: 37104681)
21. Distinct sleep disturbance and cognitive dysfunction profiles in oncology outpatients receiving chemotherapy.
Huang V; Mackin L; Kober KM; Paul SM; Cooper BA; Conley YP; Hammer MJ; Levine JD; Miaskowski C
Support Care Cancer; 2022 Nov; 30(11):9243-9254. PubMed ID: 36066629
[TBL] [Abstract][Full Text] [Related]
22. Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy.
Cerulla Torrente N; Navarro Pastor JB; de la Osa Chaparro N
J Cancer Surviv; 2020 Aug; 14(4):464-482. PubMed ID: 32146576
[TBL] [Abstract][Full Text] [Related]
23. The Effect of Exercise on Cancer-Related Cognitive Impairment and Applications for Physical Therapy: Systematic Review of Randomized Controlled Trials.
Campbell KL; Zadravec K; Bland KA; Chesley E; Wolf F; Janelsins MC
Phys Ther; 2020 Mar; 100(3):523-542. PubMed ID: 32065236
[TBL] [Abstract][Full Text] [Related]
24. Young Adults' Lived Experiences with Cancer-Related Cognitive Impairment: An Exploratory Qualitative Study.
Sharma S; Brunet J
Curr Oncol; 2023 Jun; 30(6):5593-5614. PubMed ID: 37366905
[TBL] [Abstract][Full Text] [Related]
25. Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy.
Toh YL; Shariq Mujtaba J; Bansal S; Yeo A; Shwe M; Lau AJ; Chan A
Pharmacotherapy; 2019 May; 39(5):553-563. PubMed ID: 30892712
[TBL] [Abstract][Full Text] [Related]
26. Cancer-related cognitive impairment: a mixed methods evaluation of a standard factsheet.
Lim CYS; He S; Shaw J; Dhillon HM
Support Care Cancer; 2022 Mar; 30(3):2375-2385. PubMed ID: 34741655
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Cognitive Dysfunction in Cancer Survivors.
Országhová Z; Mego M; Chovanec M
Front Mol Biosci; 2021; 8():770413. PubMed ID: 34970595
[TBL] [Abstract][Full Text] [Related]
28. The association between inflammation-related biomarkers and the subtypes of cancer-related cognitive impairment in colorectal cancer patients: A latent profile analysis.
Sun J; Dong Y; Wang D; Yang Y; Zhou Z; Zhu M; Wang T; Teng L
Eur J Oncol Nurs; 2024 Feb; 68():102493. PubMed ID: 38134496
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal evaluation of dehydroepiandrosterone (DHEA), its sulfated form and estradiol with cancer-related cognitive impairment in early-stage breast cancer patients receiving chemotherapy.
Toh YL; Tan CJ; Yap NY; Parajuli R; Lau AJ; Chan A
Sci Rep; 2022 Oct; 12(1):16552. PubMed ID: 36192413
[TBL] [Abstract][Full Text] [Related]
30. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.
Lange M; Joly F; Vardy J; Ahles T; Dubois M; Tron L; Winocur G; De Ruiter MB; Castel H
Ann Oncol; 2019 Dec; 30(12):1925-1940. PubMed ID: 31617564
[TBL] [Abstract][Full Text] [Related]
31. Cancer-related cognitive impairment in racial and ethnic minority groups: a scoping review.
Franco-Rocha OY; Lewis KA; Longoria KD; De La Torre Schutz A; Wright ML; Kesler SR
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12561-12587. PubMed ID: 37432455
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and associated factors of chemotherapy-related cognitive impairment in older breast cancer survivors.
Zhou X; Zhang X; Zhong T; Zhou M; Gao L; Chen L
J Adv Nurs; 2024 Feb; 80(2):484-499. PubMed ID: 37675947
[TBL] [Abstract][Full Text] [Related]
33. Protocol for the Exercise, Cancer and Cognition - The ECCO-Study: A Randomized Controlled Trial of Simultaneous Exercise During Neo-/Adjuvant Chemotherapy in Breast Cancer Patients and Its Effects on Neurocognition.
Kiesl D; Kuzdas-Sallaberger M; Fuchs D; Brunner S; Kommenda R; Tischler C; Hornich H; Akbari K; Kellermair J; Blessberger H; Ocenasek H; Hofmann P; Zimmer P; Vosko MR
Front Neurol; 2022; 13():777808. PubMed ID: 35401389
[TBL] [Abstract][Full Text] [Related]
34. Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study.
Duivon M; Lequesne J; Di Meglio A; Pradon C; Vaz-Luis I; Martin AL; Everhard S; Broutin S; Rigal O; Bousrih C; Lévy C; Lerebours F; Lange M; Joly F
Breast Cancer Res; 2024 Jun; 26(1):93. PubMed ID: 38840166
[TBL] [Abstract][Full Text] [Related]
35. The high burden of symptoms associated with cognitive impairment in lung cancer patients: A latent class analysis.
Luo J; Liu R; Luo Y; Fang Q; Liu S; Yang Z; Miao J; Zhang L
Asia Pac J Oncol Nurs; 2023 Apr; 10(4):100200. PubMed ID: 36890861
[TBL] [Abstract][Full Text] [Related]
36. Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer.
Yap NY; Tan NYT; Tan CJ; Loh KW; Ng RCH; Ho HK; Chan A
Breast Cancer Res Treat; 2020 Oct; 183(3):683-696. PubMed ID: 32696315
[TBL] [Abstract][Full Text] [Related]
37. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
38. Associations of brain-derived neurotrophic factor rs6265 polymorphism and cognitive function in breast cancer survivors from a cross-sectional study.
Goto T; Saligan LN; Li X; Xiang L; Kwiat C; Nguyen C; Crouch A; Von Ah D
Cancer Med; 2024 Jan; 13(2):e6975. PubMed ID: 38379321
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal Analysis of Patient-Reported Cognitive Function in Multiple Myeloma.
Yusuf ARS; Heiling HM; Deal AM; Jensen CE; Mangieri NJ; Nyrop KA; Lichtman EI; Rubinstein SM; Grant SJ; Wood WA; Tuchman SA; Nakamura ZM
Clin Lymphoma Myeloma Leuk; 2022 Dec; 22(12):920-927. PubMed ID: 36085276
[TBL] [Abstract][Full Text] [Related]
40. Cancer-related cognitive impairment in survivors of adolescent and young adult non-central nervous system cancer: A scoping review.
Vizer LM; Mikles SP; Piepmeier AT
Psychooncology; 2022 Aug; 31(8):1275-1285. PubMed ID: 35726379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
